NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
49401-102-01 | 49401-102 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20110310 | N/A | BLA | BLA125370 | GlaxoSmithKline LLC | BELIMUMAB | 400 mg/5mL | 1 VIAL in 1 CARTON (49401-102-01) / 5 mL in 1 VIAL |
49401-101-01 | 49401-101 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20110310 | N/A | BLA | BLA125370 | GlaxoSmithKline LLC | BELIMUMAB | 120 mg/1.5mL | 1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL |